NCT02469155 - A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment | Biotech Hunter

Enrollment

696

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Schizophrenia

Interventions

DRUG

ITI-007

DRUG

Risperidone

DRUG

Placebo

Trial Locations (11)

Clinical Site, Little Rock

Clinical Site, Springdale

Clinical Site, Culver City

Clinical Site, Lemon Grove

Clinical Site, Long Beach

Clinical Site, San Diego

Clinical Site, North Miami

Clinical Site, Berlin

Clinical Site, Marlton

Clinical Site, Austin

Clinical Site, Dallas